Squarepoint
TRDA icon

Squarepoint’s Entrada Therapeutics TRDA Stock Holding History

Squarepoint’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,208
Closed -$75.3K – 5008
2025
Q2 		$75.3K Buy
+11,208
New +$90.2K ﹤0.01% 4228
2024
Q4 		– Sell
-41,568
Closed -$664K – 5504
2024
Q3 		$664K Buy
41,568
+15,618
+60% +$246K ﹤0.01% 2912
2024
Q2 		$370K Sell
25,950
-8,151
-24% -$116K ﹤0.01% 3293
2024
Q1 		$483K Buy
+34,101
New +$482K ﹤0.01% 3066

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return